Tannic Acid and Copper-Modified ZIF-8 Metal Organic Framework as a Cefotaxime Delivery System for Antimicrobial Activity
Özet
Objectives: Antibiotic resistance has become a global public health threat. Cefotaxime (CTX), a third-generation cephalosporin, is approved for use in infants, children, and adults with various microbial infections, particularly those affecting the central nervous system. This study aimed to synthesize and characterize zeolitic imidazolate framework (ZIF)-8-based drug delivery systems (DDSs) to enhance antimicrobial activity and control CTX release. Materials and Methods: ZIF-8 was synthesized via the coordination network of Zn ions and 2-methylimidazole and subsequently modified with tannic acid (TA) and copper ions (Cu2+). ZIF-8 MOF and its derivatives were characterized by Fourier Transform Infrared, zeta potential, in vitro dissolution rate, and in vitro antimicrobial activity. Conclusion: ZIF-8 MOF DDS may serve as an alternative for delivering drugs to infected areas due to their controlled release under low pH conditions. Results: The drug loading capacity and encapsulation efficiency were found to be 39.50 ± 1.19% and 98.75 ± 2.96%, respectively, for ZIF-8@ TA@CTX, and 40.75 ± 1.22% and 97.75 ± 2.93%, respectively, for ZIF-8@TA@Cu@CTX. Following 48 hours, the drug released from ZIF-8@TA@ Cu@CTX was detected at 62.83 ± 1.89% at pH 5.0 and 83.19 ± 2.50% at pH 7.4 after 48 h, with dissolution profiles best fitting the Korsmeyer– Peppas model. The synthesized DDSs demonstrated a higher antibacterial activity against gram-positive bacteria than against gram-negative bacteria.
Anahtar Kelimeler
- Scopus
- 0
- WoS
- 1
- OpenAlex
- 0
- TR Dizin
- 0
Tam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | Tok, Yağmur Pirinççi | |
| dc.contributor.author | Özsoy, Münteha | |
| dc.contributor.author | Çelik, Damla Damar | |
| dc.date.accessioned | 2026-10-27T23:47:44.849554154Z | |
| dc.date.available | 2026-10-27T23:47:44.849554154Z | |
| dc.date.issued | 2026 | |
| dc.description.abstract | Objectives: Antibiotic resistance has become a global public health threat. Cefotaxime (CTX), a third-generation cephalosporin, is approved for use in infants, children, and adults with various microbial infections, particularly those affecting the central nervous system. This study aimed to synthesize and characterize zeolitic imidazolate framework (ZIF)-8-based drug delivery systems (DDSs) to enhance antimicrobial activity and control CTX release. Materials and Methods: ZIF-8 was synthesized via the coordination network of Zn ions and 2-methylimidazole and subsequently modified with tannic acid (TA) and copper ions (Cu2+). ZIF-8 MOF and its derivatives were characterized by Fourier Transform Infrared, zeta potential, in vitro dissolution rate, and in vitro antimicrobial activity. Conclusion: ZIF-8 MOF DDS may serve as an alternative for delivering drugs to infected areas due to their controlled release under low pH conditions. Results: The drug loading capacity and encapsulation efficiency were found to be 39.50 ± 1.19% and 98.75 ± 2.96%, respectively, for ZIF-8@ TA@CTX, and 40.75 ± 1.22% and 97.75 ± 2.93%, respectively, for ZIF-8@TA@Cu@CTX. Following 48 hours, the drug released from ZIF-8@TA@ Cu@CTX was detected at 62.83 ± 1.89% at pH 5.0 and 83.19 ± 2.50% at pH 7.4 after 48 h, with dissolution profiles best fitting the Korsmeyer– Peppas model. The synthesized DDSs demonstrated a higher antibacterial activity against gram-positive bacteria than against gram-negative bacteria. | |
| dc.identifier.doi | 10.4274/tjps.galenos.2026.80025 | |
| dc.identifier.eissn | 2148-6247 | |
| dc.identifier.endpage | 40 | |
| dc.identifier.issn | 1304-530X | |
| dc.identifier.issue | 1 | |
| dc.identifier.pmcid | PMC13360780 | |
| dc.identifier.pmid | 41960755 | |
| dc.identifier.scopus | 2-s2.0-105046044829 | |
| dc.identifier.startpage | 31 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/kostu/10699 | |
| dc.identifier.volume | 23 | |
| dc.identifier.wos | WOS:001823396600001 | |
| dc.language.iso | en | |
| dc.publisher | Turkish Pharmacists Association | |
| dc.relation.ispartof | Turkish Journal of Pharmaceutical Sciences | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | Antibiotic resistance | |
| dc.subject | cefotaxime | |
| dc.subject | metal organic framework | |
| dc.subject | zeolitic imidazolate frameworks | |
| dc.subject.classification | Pharmacology & Pharmacy | |
| dc.subject.other | cefotaxime | |
| dc.subject.other | cephalosporin | |
| dc.subject.other | copper | |
| dc.subject.other | metal organic framework | |
| dc.subject.other | methyl group | |
| dc.subject.other | tannin | |
| dc.subject.other | unclassified drug | |
| dc.subject.other | Zeolitic imidazolate framework 8 | |
| dc.subject.other | zinc ion | |
| dc.subject.other | antibacterial activity | |
| dc.subject.other | antibiotic resistance | |
| dc.subject.other | antimicrobial activity | |
| dc.subject.other | Article | |
| dc.subject.other | central nervous system | |
| dc.subject.other | centrifugation | |
| dc.subject.other | controlled study | |
| dc.subject.other | dissolution | |
| dc.subject.other | drug delivery system | |
| dc.subject.other | drug release | |
| dc.subject.other | encapsulation | |
| dc.subject.other | Fourier transform infrared spectroscopy | |
| dc.subject.other | Gram negative bacterium | |
| dc.subject.other | in vitro study | |
| dc.subject.other | in vivo study | |
| dc.subject.other | minimum bactericidal concentration | |
| dc.subject.other | minimum inhibitory concentration | |
| dc.subject.other | nonhuman | |
| dc.subject.other | particle size | |
| dc.subject.other | pH | |
| dc.subject.other | Pseudomonas aeruginosa | |
| dc.subject.other | Staphylococcus aureus | |
| dc.subject.other | ultraviolet visible spectroscopy | |
| dc.subject.other | zeta potential | |
| dc.title | Tannic Acid and Copper-Modified ZIF-8 Metal Organic Framework as a Cefotaxime Delivery System for Antimicrobial Activity | |
| dc.type | Article | |
| rdl.citation.openalex | 0 | |
| rdl.citation.scopus | 0 | |
| rdl.citation.trdizin | 0 | |
| rdl.citation.wos | 1 | |
| rdl.department | İstanbul Health and Technology University Faculty of Pharmacy, Department of Pharmaceutical Technology, İstanbul, Türkiye | |
| rdl.department | Kocaeli Health and Technology University Faculty of Pharmacy, Department of Pharmaceutical Toxicology, Kocaeli, Türkiye | |
| rdl.department | Marmara University Faculty of Pharmacy, Department of Pharmaceutical Microbiology, İstanbul, Türkiye | |
| rdl.oa.status | gold | |
| rdl.oa.status | green | |
| rdl.scopus.quartile | Q2 | |
| rdl.sdg | SDG03 | |
| rdl.source.index | SCOPUS | |
| rdl.source.index | WOS | |
| rdl.source.index | TRDIZIN | |
| rdl.source.index | PUBMED | |
| rdl.wos.index | Emerging Sources Citation Index (ESCI) |


